Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1981-5-13
|
pubmed:abstractText |
The effect of pneumococcal vaccination on antibodies to Streptococcus pneumoniae type 14, group B streptococcus type III, and AB blood group antigens was studied in 40 vaccinated adults. Fourfold or greater increases in type-specific IgG antibody to Pn-14 were found in 26 of 40 vaccines (mean increase 6.4-fold) and against GBS-III in 16 of the 40 (mean increase 2.9-fold) by an indirect immunofluorescence assay. However, only six of the 26 vaccinees with low levels (titers less than or equal to 20) of GBS-III antibody in prevaccination sera developed titers greater than 20 after vaccination. Thus, vaccination with polyvalent pneumococcal vaccine does not reliably induce high levels of IF antibody to GBS-III. Fourfold or greater increases in IgG isohemagglutinins against blood group A cells were also found in 22 of 27 vaccines (mean increase 4.5-fold) and against blood group B cells in nine of 34 (mean increase 1.7-fold) using the indirect anti-human globulin test. Chromatographic fractionation of selected sera confirmed that the anti-A isohemagglutinins stimulated in group O subjects were of the IgG class. Thus, pneumococcal vaccination during incompatible pregnancy could potentiate AO hemolytic disease of the newborn infant.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ABO Blood-Group System,
http://linkedlifedata.com/resource/pubmed/chemical/Agglutinins,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M,
http://linkedlifedata.com/resource/pubmed/chemical/Isoantibodies
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-3476
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
98
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
374-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7009817-ABO Blood-Group System,
pubmed-meshheading:7009817-Adult,
pubmed-meshheading:7009817-Aged,
pubmed-meshheading:7009817-Agglutinins,
pubmed-meshheading:7009817-Antibodies, Bacterial,
pubmed-meshheading:7009817-Antibody Formation,
pubmed-meshheading:7009817-Bacterial Vaccines,
pubmed-meshheading:7009817-Female,
pubmed-meshheading:7009817-Humans,
pubmed-meshheading:7009817-Immunoglobulin G,
pubmed-meshheading:7009817-Immunoglobulin M,
pubmed-meshheading:7009817-Isoantibodies,
pubmed-meshheading:7009817-Male,
pubmed-meshheading:7009817-Middle Aged,
pubmed-meshheading:7009817-Pneumococcal Infections,
pubmed-meshheading:7009817-Streptococcus agalactiae,
pubmed-meshheading:7009817-Streptococcus pneumoniae
|
pubmed:year |
1981
|
pubmed:articleTitle |
Antibody response to group B streptococcus type III and AB blood group antigens induced by pneumococcal vaccine.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|